#USA #healthcare #Minneapolis #Investor Conferences #Bio-Techne

Bio-Techne Corporation's Upcoming Investor Presentations

Bio-Techne Corporation, listed under NASDAQ as TECH, is set to engage with investors at several prominent conferences this June. This initiative highlights the company's commitment to transparency and its focus on bolstering relationships with shareholders while showcasing its innovative products and solutions.

The presentations are scheduled as follows:

• - William Blair 45th Annual Growth Stock Conference on June 3, 2025, at 2:40 PM CDT.
• - Jefferies Global Healthcare Conference on June 4, 2025, at 3:45 PM EDT.
• - Goldman Sachs 46th Annual Global Healthcare Conference on June 10, 2025, at 10:40 AM EDT.

For those unable to attend in person, a live webcast will be accessible through Bio-Techne's Investor Relations website, ensuring that a broad audience can stay informed about the company’s advancements and strategic outlook. The webcasts can be found at the IR Calendar page.

About Bio-Techne

Established as a leader in the life sciences sector, Bio-Techne Corporation delivers a diverse array of cutting-edge tools and bioactive reagents tailored for both research and clinical diagnostics. Their extensive product lineup significantly contributes to scientific research, enhancing our understanding of biological processes, various diseases, and drug discovery initiatives.

In the fiscal year of 2024, Bio-Techne reported an impressive $1.2 billion in net sales, a testament to its robust business model and the essential role it plays within the research community. The corporation employs approximately 3,100 individuals worldwide, reflecting its status as a significant employer in the biotechnology realm.

Bio-Techne's commitment to advancing health and research continues to drive its innovation pipeline, addressing crucial scientific needs with an eye towards future developments. As the global demand for reliable diagnostics and biopharmaceutical advancements grows, Bio-Techne positions itself to be at the forefront, offering state-of-the-art solutions that enable breakthroughs in various medical fields.

For further information about Bio-Techne and its extensive range of products, you can visit their official website at Bio-Techne. Additionally, they maintain an active social media presence on platforms such as Facebook, LinkedIn, Twitter, and YouTube, where they share updates and insights on their latest innovations.

In conclusion, as we approach these investor conferences, stakeholders are encouraged to stay tuned for live updates and detailed insights into the future directions that Bio-Techne aims to pursue. The company's continual push for innovation and transparency is likely to engage investors and enthusiasts alike, proving its unwavering commitment to enhancing life sciences and healthcare outcomes overall.